Medicine Technology 🌱 Environment Space Energy Physics Engineering Social Science Earth Science Science
Science 2026-03-20

Drinking more water didn't prevent kidney stones - even with smart bottles and coaching

The largest behavioral trial for kidney stone prevention found that structured hydration programs boosted fluid intake but failed to reduce stone recurrence over two years.

One in eleven Americans will develop a kidney stone. Nearly half of them will get another. The standard medical advice for decades has been simple and intuitive: drink more water. Dilute the minerals in your urine, and crystals won't form. It makes clean biological sense. But does it actually work when tested rigorously?

The answer, according to the largest behavioral trial ever conducted for kidney stone prevention, is more complicated than anyone hoped.

Smart bottles, cash incentives, and 1,658 patients

The trial, published March 19 in The Lancet, enrolled 1,658 adolescents and adults across six major U.S. medical centers: UT Southwestern, Washington University in St. Louis, the University of Pennsylvania, Children's Hospital of Philadelphia, the University of Washington, Mayo Clinic, and Cleveland Clinic. Coordinated by the Duke Clinical Research Institute through the Urinary Stone Disease Research Network, it was designed to answer a question that had never been tested at this scale - whether a structured behavioral program could get people to drink enough fluids to prevent stones from coming back.

Half the participants received standard care. The other half got an intensive hydration program that included Bluetooth-enabled smart water bottles tracking their intake in real time, personalized "fluid prescriptions" based on each person's baseline urine output, financial incentives for hitting targets, text message reminders, and regular health coaching sessions.

The fluid prescription itself was individually calculated. Researchers measured how much urine a participant typically produced, then determined how much additional water they needed to drink to reach a urine output of at least 2.5 liters per day - a threshold widely considered protective against stone formation.

More water in, same stones out

The program worked in one sense: people in the intervention group did drink more. Their average urine output increased. But the increase was not large enough to translate into fewer symptomatic kidney stone episodes across the overall study population over two years of follow-up.

That gap between intention and outcome is the crux of the study's findings. Even with daily digital tracking, personalized goals, financial rewards, and professional coaching, most participants could not sustain the high fluid intake levels needed to meaningfully shift their stone risk. The adherence challenge was persistent and widespread.

"The trial results show that despite the importance of high fluid intake to prevent stone recurrence, achieving and maintaining very high fluid intake is more challenging than we often assume," said Charles Scales, M.D., associate professor at Duke University School of Medicine and corresponding co-senior author of the paper.

Why drinking enough is harder than it sounds

The finding may surprise anyone who thinks of hydration as a simple lifestyle fix. But consider what 2.5 liters of daily urine output actually demands. Depending on climate, activity level, and diet, that can require drinking three liters of fluid or more every day - roughly twelve to thirteen cups. That is a substantial behavioral change, and it needs to happen every single day, indefinitely.

Work schedules interfere. People forget. Access to bathrooms matters - long-haul truck drivers, teachers, and surgical nurses cannot pause to drink water every thirty minutes. The study highlights how the gap between medical recommendation and daily reality can be vast, even when patients are highly motivated. These are people who have already experienced kidney stone pain, widely described as among the most intense pain a person can endure. If anyone should be motivated to drink more water, it is them.

"Kidney stone disease is a chronic condition, punctuated by unpredictable, sometimes excruciatingly painful episodes that can disrupt work, sleep, productivity and life in general," said Alana Desai, M.D., first author and principal investigator at the Washington University site. "Most people would appreciate a simple means to reduce their chances of experiencing another event."

A first for measuring what actually matters

One distinguishing feature of this trial was its primary endpoint. Previous hydration studies for kidney stones had typically measured surrogate outcomes - did people drink more? Did their urine become more dilute? This trial instead measured actual stone recurrence, using regular surveys and imaging to track whether new stones formed or existing ones grew. That is a harder bar to clear, and a more honest one.

The distinction matters because a treatment can change a biomarker without changing the disease. Urine volume went up, but stones kept forming. This forces a reconsideration of whether the hydration targets used in clinical practice are correctly calibrated, or whether the relationship between fluid intake and stone prevention is less linear than assumed.

Toward personalized hydration - or beyond hydration entirely

The researchers are not concluding that hydration is irrelevant. Instead, they argue the findings point toward the need for more individualized approaches. A single fluid target may not work across diverse patients whose hydration needs vary with age, body size, lifestyle, climate, and underlying health conditions.

"Rather than asking every patient to meet the same fluid goal, we should determine who benefits from which targets, understand why adherence breaks down, and build interventions - behavioral and medical - that reliably reduce stone recurrence," said Gregory E. Tasian, M.D., co-senior author and attending pediatric urologist at Children's Hospital of Philadelphia.

The study also opens the door to exploring non-hydration strategies. Researchers noted the need to investigate pharmacological approaches that keep minerals dissolved in urine, as well as strategies that address the structural barriers to drinking enough - workplace constraints, lifestyle factors, and the sheer difficulty of maintaining a demanding daily habit for years.

What this trial cannot tell us

Several limitations deserve attention. The trial measured whether the behavioral program reduced stone recurrence across the entire group, but subgroup analyses might reveal populations for whom higher fluid intake does help. People who achieved and sustained the 2.5-liter urine output target may have had better outcomes - the challenge was that too few managed it consistently.

The two-year follow-up, while longer than many behavioral studies, may also be insufficient for a condition with recurrence timelines that stretch over decades. And the study population, drawn from major academic medical centers, may not reflect the full diversity of kidney stone patients, particularly those in rural settings or without access to specialty care.

The trial also focused on behavioral hydration support and did not test whether combining increased fluids with dietary changes or medications would produce different results. Kidney stone formation depends on multiple factors beyond urine volume, including calcium, oxalate, and citrate levels, urine pH, and individual metabolic differences.

The finding also has implications for clinical communication. For decades, urologists have told patients with kidney stones to drink more water as a primary prevention strategy. This trial does not invalidate that advice, but it complicates the certainty with which it is delivered. Telling a patient that hydration prevents stones, when the best available evidence shows most people cannot maintain the required intake levels, sets up a dynamic where recurrence feels like personal failure. A more honest message - that hydration helps but is extremely difficult to sustain, and that other approaches may be needed - could reduce patient frustration and open the door to combination strategies.

Still, the study's scale and rigor make its central message hard to ignore: telling people to drink more water, even when backed by sophisticated technology and personalized coaching, is not enough to solve kidney stone recurrence for most patients. The field needs to move beyond one-size-fits-all hydration advice and toward a more precise, multi-pronged approach to prevention.

Source: Study published March 19 in The Lancet by the Urinary Stone Disease Research Network, coordinated by the Duke Clinical Research Institute. The trial enrolled 1,658 participants across six U.S. clinical centers. Lead author: Alana Desai, M.D. (Washington University in St. Louis). Co-senior authors: Charles Scales, M.D. (Duke University) and Gregory E. Tasian, M.D. (Children's Hospital of Philadelphia). Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.